PRKG2

protein kinase cGMP-dependent 2, the group of AGC family kinases

Basic information

Region (hg38): 4:81087370-81215222

Links

ENSG00000138669NCBI:5593OMIM:601591HGNC:9416Uniprot:Q13237AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • acromesomelic dysplasia 4 (Strong), mode of inheritance: AR
  • acromesomelic dysplasia 4 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spondylometaphyseal dysplasia, Pagnamenta type; Acromesomelic dysplasia 4ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Musculoskeletal33106379; 34782440

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRKG2 gene.

  • not provided (2 variants)
  • Acromesomelic dysplasia 4 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRKG2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
3
clinvar
7
missense
1
clinvar
23
clinvar
1
clinvar
25
nonsense
2
clinvar
2
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
2
2
non coding
2
clinvar
2
clinvar
4
Total 3 1 23 7 5

Variants in PRKG2

This is a list of pathogenic ClinVar variants found in the PRKG2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
4-81089714-G-GT Spondylometaphyseal dysplasia, pagnamenta type Pathogenic (Oct 14, 2022)1326259
4-81092426-C-A Inborn genetic diseases Uncertain significance (Nov 27, 2023)3218861
4-81092465-A-AAAGG Benign (Jan 08, 2024)2798131
4-81092465-A-AAAGGAAGG Likely benign (Jan 12, 2024)2975970
4-81092465-A-AAAGGAAGGAAGG Likely benign (Jan 08, 2024)2975909
4-81104365-T-C PRKG2-related disorder Likely benign (Aug 01, 2022)1711591
4-81105941-TAGAG-T PRKG2-related disorder Likely benign (Jun 19, 2019)3043457
4-81110454-G-A Inborn genetic diseases Uncertain significance (Feb 28, 2024)3218860
4-81110459-G-A PRKG2-related disorder Likely benign (Oct 28, 2019)3050415
4-81110483-T-TTACGCTCTTAAAGTATATACACTTTATCACTAGTTAGGTTATTTTTGCATTTCTCTGAAGAGGTG Pathogenic (Jul 05, 2022)2164608
4-81110486-C-CGCTCTTAAAGTATATACACTTTATCACTAGTTAGGTTATTTTTGCATTTCTCTGAAGAGGTGGCTG Pathogenic (Jul 05, 2022)2171670
4-81110595-G-A Inborn genetic diseases Uncertain significance (Apr 22, 2022)2285172
4-81135195-G-A Inborn genetic diseases Uncertain significance (Mar 21, 2024)3310208
4-81135226-G-A Acromesomelic dysplasia 4 Pathogenic (Oct 14, 2022)1326257
4-81135289-A-T Inborn genetic diseases Uncertain significance (Sep 14, 2022)2312340
4-81137475-G-A Inborn genetic diseases Uncertain significance (Jul 12, 2023)2611121
4-81140534-T-G Inborn genetic diseases Uncertain significance (Mar 20, 2023)2568595
4-81140627-T-C Inborn genetic diseases Uncertain significance (Dec 01, 2022)2331128
4-81140668-A-C Acromesomelic dysplasia 4 Likely pathogenic (-)2501812
4-81142876-G-T Inborn genetic diseases Uncertain significance (Dec 14, 2023)3218859
4-81142936-G-A Inborn genetic diseases Uncertain significance (Dec 15, 2022)2209142
4-81144235-G-A Inborn genetic diseases Uncertain significance (Apr 07, 2023)2513606
4-81144312-G-A PRKG2-related disorder Likely benign (Jun 27, 2019)3043024
4-81148883-C-T Acromesomelic dysplasia 4 Pathogenic (May 11, 2023)2502276
4-81151986-T-C PRKG2-related disorder Benign (Aug 12, 2019)3034773

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRKG2protein_codingprotein_codingENST00000395578 18126382
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6470.3531257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.992313990.5790.00002025006
Missense in Polyphen601460.410961851
Synonymous-0.7081561451.070.000007121416
Loss of Function4.79942.90.2100.00000220532

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005780.0000578
Ashkenazi Jewish0.000.00
East Asian0.0001140.000109
Finnish0.00004630.0000462
European (Non-Finnish)0.00006190.0000615
Middle Eastern0.0001140.000109
South Asian0.0001320.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Crucial regulator of intestinal secretion and bone growth (By similarity). Phosphorylates and activates CFTR on the plasma membrane. Plays a key role in intestinal secretion by regulating cGMP-dependent translocation of CFTR in jejunum (By similarity). Acts downstream of NMDAR to activate the plasma membrane accumulation of GRIA1/GLUR1 in synapse and increase synaptic plasticity. Phosphorylates GRIA1/GLUR1 at Ser-863 (By similarity). Acts as regulator of gene expression and activator of the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2 in mechanically stimulated osteoblasts. Under fluid shear stress, mediates ERK activation and subsequent induction of FOS, FOSL1/FRA1, FOSL2/FRA2 and FOSB that play a key role in the osteoblast anabolic response to mechanical stimulation (By similarity). {ECO:0000250|UniProtKB:Q61410, ECO:0000250|UniProtKB:Q64595}.;
Pathway
Platelet activation - Homo sapiens (human);Regulation of lipolysis in adipocytes - Homo sapiens (human);Long-term depression - Homo sapiens (human);Gap junction - Homo sapiens (human);Circadian entrainment - Homo sapiens (human);Thermogenesis - Homo sapiens (human);Renin secretion - Homo sapiens (human);Salivary secretion - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);NO-cGMP-PKG mediated Neuroprotection;Signaling by WNT;Signal Transduction;ion channels and their functional role in vascular endothelium;Metabolism;actions of nitric oxide in the heart;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation;Metabolism of cofactors;Metabolism of vitamins and cofactors;IL-7 signaling;Ca2+ pathway;Beta-catenin independent WNT signaling;Hemostasis;JAK STAT pathway and regulation;EPO signaling;cGMP effects;Nitric oxide stimulates guanylate cyclase;VEGF;Platelet homeostasis (Consensus)

Recessive Scores

pRec
0.223

Intolerance Scores

loftool
0.219
rvis_EVS
-0.84
rvis_percentile_EVS
11.18

Haploinsufficiency Scores

pHI
0.277
hipred
Y
hipred_score
0.756
ghis
0.530

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.834

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prkg2
Phenotype
growth/size/body region phenotype; craniofacial phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; skeleton phenotype;

Gene ontology

Biological process
protein phosphorylation;signal transduction;peptidyl-serine autophosphorylation;cofactor metabolic process;protein localization to plasma membrane;negative regulation of chloride transport
Cellular component
cytosol;apical plasma membrane;nuclear membrane
Molecular function
protein kinase activity;cGMP-dependent protein kinase activity;ATP binding;cGMP binding;protein homodimerization activity